Based in the UK, Halma is a FTSE 100 global group of life-saving technology companies. Halma identifies and invests in companies that provide innovative solutions to many of the key problems facing the world today.
Founded in 1995, PeriGen is the market leader in applying artificial intelligence (AI) to improve safety in childbirth. Its unique technology identifies troubling trends during the course of labour and mitigates the primary causes of adverse events in childbirth.
PeriGen’s PeriWatch® platform provides consistent analysis and efficient display of complex data in real-time to promote better human recognition and communication about impending problems during labour.
In joining Halma, PeriGen gains a stronger platform for long-term growth. The acquisition provides access to a supportive network and additional resources so that PeriGen can continue to expand its perinatal safety technology throughout the US and beyond.
Halma is a global group of life-saving technology companies, focused on growing a safer, cleaner, healthier future for everyone, every day. Its purpose defines the three broad market areas where it operates:
· Safety: protecting life as populations grow and protecting worker safety.
· Environment: improving food and water quality, and monitoring air pollution.
· Health: meeting rising healthcare demand as growing populations age and lifestyles change.
Halma employs over 7,000 people in more than 20 countries, with major operations in the UK, Europe, the USA and Asia Pacific. Halma is listed on the London Stock Exchange (LON: HLMA) and is a constituent of the FTSE 100 index.
In January 2021, Halma was named Britain's Most Admired Company by Management Today.
Founded in 1995, PeriGen is a market leader in applying artificial intelligence to improve safety in childbirth. The company offers innovative perinatal software solutions that incorporate advanced statistical analysis features to enhance clinical efficiency and standardization of care during childbirth.
Led by skilled obstetrics practitioners and technology professionals, PeriGen has created the PeriWatch® platform to provide consistent analysis and timely display of complex data in real-time to promote better human recognition and communication about impending problems during labor. With PeriWatch®, clinicians can spend more time on direct patient care and less time on manual calculations and data manipulation.
Bryan, Garnier & Co identified PeriGen, approached the company on behalf of Halma, and provided process and business intelligence to the client.
This transaction builds on Bryan, Garnier & Co’s first-rate expertise and track record with tech-enabled companies in the healthcare sector.
Notable other transactions include the acquisition of Maincare Solutions by Montagu Private Equity, and more recently the sale of French telemedicine leader Qare.